The Diabetes Control and Complications Trial Re search Group. The effects of intensive insulin treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus.N Engl J Med.1993; 329: 977–86.
4.
ParvingH., AndersenA., SmidtU., SvendsenP.Early aggressive anti-hypertensive treatment reduces rate of decline in kidney function in diabetic nephropathy.Lancet.1983; II: 1175–9.
5.
LewisE.J., HunsickerL.G., BainR.P., RohdeR.D.The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy.N Engl J Med.1993; 329: 1456–62.
6.
AyoS.H., RadnikR.A., GaroniJ.A., GlassWFII, KreisbergJ.I.High glucose causes an increase in extracellular matrix proteins in cultured mesangial cells.Am J Pathol.1990; 136: 1339–48.
ZiyadehF.N.Mediators of hyperglycemia and the pathogenesis of matrix accumulation in diabetic renal disease.Miner Electrolyte Metab.1995; 21: 292–302.
10.
RoccoM., ChenY., GoldfarbS., ZiyadehF.N.Elevated glucose stimulates TGF -β gene expression and bioactivity in proximal tubule.Kidney Int.1992; 41: 107–14.
11.
WolfG., SharmaK., ChenY., EricksenM., ZiyadehF.N.High glucose-induced proliferation in mesangial cells is reversed by autocrine TGF-β.Kidney Int.1992; 42: 647–56.
12.
SharmaK., ZiyadehF.N.Biochemical events and cytokine interactions linking glucose metabolism to the development of diabetic nephropathy.Semin Nephrol.1997; 17: 80–92.
13.
WolfG., ZiyadehF.The role of angiotensin II in diabetic nephropathy: Emphasis on nonhemodynamic mechanisms.Am J Kidney Dis.1997; 29: 153–63.
14.
ZiyadehF.N., HanD.C., CohenJ.A., GuoJ., CohenM.P.Glycated albumin stimulates fibronectin gene expression in glomerular mesangial cells: Involvement of the transforming growth factor-β system.Kidney Int.1998; 53: 631–8.
15.
KoyaD., JirousekM.R., LinY.W., IshiiH., KubokiK., KingG.L.Characterization of protein kinase C β-isoform activation on the gene expression of transforming growth factor-β, extracellular matrix components, and prostanoids in the glomeruli of diabetic rats.J Clin Invest.1997; 100: 115–26.
16.
Kolm-LittyV., SauerU., NerlichA., LehmannR., SchleicherE.D.High glucose-induced transforming growth factor β1 production is mediated by the hexosamine pathway in porcine glomerular mesangial cells.J Clin Invest.1998; 101: 160–9.
17.
Di PaoloS., GesualdoL., RanieriE., GrandalianoG., SchenaF.P.High glucose concentration induces the overexpression of transforming growth factor-β through the activation of a platelet-derived growth factor loop in human mesangial cells.Am J Pathol.1996; 149: 2095–106.
18.
PhillipsA.O., SteadmanR., TopleyN., WilliamsJ.D.Elevated D-glucose concentrations modulate TGF -beta 1 synthesis by human cultured renal proximal tubular cells. The permissive role of platelet-derived growth factor.Am J Pathol.1995; 147: 362–74.
19.
StuderR.K., NegreteH., CravenP.A., DeRubertisF.R.Protein kinase C signals thromboxane induced increases in fibronectin synthesis and TGF -beta bioactivity in mesangial cells.Kidney Int.1995; 48: 422–30.
20.
SharmaK., ZiyadehF.N.Hyperglycemia and diabetic kidney disease: The case for transforming growth factor-β as a key mediator.Diabetes.1995; 44: 1139–46.
21.
NakamuraT., FukuiM., EbiharaI., OsadaS., NagaokaI., TominoY.mRNA expression of growth factors in glomeruli from diabetic rats.Diabetes.1993; 42: 450–6.
22.
SharmaK., ZiyadehF.N.Renal hypertrophy is associated with upregulation of TGF-β1 gene expression in diabetic BB rat and NOD mouse.Am J Physiol.1994; 267: FI094–101.
23.
ShanklandS.J., ScholeyJ.W.Expression of transforming growth factor-β1 during diabetic renal hypertrophy.Kidney Int.1994; 46: 430–42.
24.
PankewyczO.G., GuanJ.X., BoltonW.K., GomezA., BenedictJ.F.Renal TGF -beta regulation in spontaneously diabetic NOD mice with correlations in mesangial cells.Kidney Int.1994; 46: 748–58.
25.
YamamotoT., NakamuraT., NobleN.A., RuoslahtiE., BorderW.A.Expression of transforming growth factor beta is elevated in human and experimental diabetic nephropathy.Proc Natl Acad Sci U S A.1993; 90: 1814–18.
26.
IwanoM., AtsushiK., NishinoT., SatoH., NishiokaH., AkaiY.Quantification of glomerular TGF-β1 mRNA in patients with diabetes mellitus.Kidney Int.1996; 49: 1120–6.
27.
SharmaK., ZiyadehF.N., AlzahabiB., McGowanT.A., KapoorS., KurnikB.R.C.Increased renal production of transforming growth factor-β 1 in patients with type II diabetes.Diabetes.1997; 46: 854–9.
28.
van DetN.F., VerhagenN.A.M., TamsmaJ.T., BerdenJ.H.M., BruijnJ.A., DahaM.R.Regulation of glomerular epithelial cell production of fibronectin and transforming growth factor-β by high glucose, not by angiotensin II.Diabetes.1997; 46: 834–40.
29.
HanD.C., HoffmanB.B., ZiyadehF.N.High glucose stimulates proliferation and collagen type I synthesis in renal cortical fibroblasts: Mediation by autocrine activation of TGF-β [Abstract].J Am Soc Nephrol.1997; 8: 516A.
30.
ZiyadehF.N., SharmaK., EricksenM., WolfG.Stimulation of collagen gene expression and protein synthesis in murine mesangial cells by high glucose is mediated by activation of transforming growth factor-β.J Clin Invest.1994; 93: 536–42.
31.
KolmV., SauerU., OlgemollerB., SchleicherE.D.High glucose-induced TGF -β 1 regulates mesangial production of heparan sulfate proteoglycan.Am J Physiol.1996; 270: F812–21.
32.
SharmaK., GuoJ., JinY., ZiyadehF.N.Neutralization of TGF-β by anti-TGF-β antibody attenuates kidney hypertrophy and the enhanced extracellular matrix gene expression in STZ-induced diabetic mice.Diabetes.1996; 45: 522–30.
33.
HoffmanB.B., HanD.C., GuoJ., ZiyadehF.N.Treatment with antisense TGF -β1 oligodeoxynucleotide diminishes kidney hypertrophy and matrix mRNA levels in diabetic mice [Abstract].J Am Soc Nephrol.1998; 9: 632A.
34.
ZiyadehF.N., HoffmanB.B., GuoJ., EltayebB.O., HanD.C., SharmaK.Amelioration of renal insufficiency and excess matrix gene expression by chronic treatment with anti-TGF-β antibody in db/db mice [Abstract].J Am Soc Nephrol.1998; 9: 646A.
35.
TerrellT.G., WorkingP.K., ChowC.P., GreenJ.D.Pathology of recombinant human transforming growth factor-β1 in rats and rabbits.Int Rev Exp Pathol.1993; 34B: 43–67.
36.
IsakaY., FuijiwaraY., UedaN., KanedaY., KamadaT., ImaiE.Glomerulosclerosis induced by in vivo transfection of transforming growth factor-β or platelet derived growth factor gene into the rat kidney.J Clin Invest.1993; 92: 2597–601.
ClouthierD.E., ComerfordS.A., HammerR.E.Hepatic fibrosis, glomerulosclerosis, and a lipodystrophy -like syndrome in PEPCK-TGF-betal transgenic mice.J Clin Invest.1997; 100: 2697–713.
39.
YamamotoT., NobleN.A., CohenA.H., NastC.C., HishidaA., GoldL.I.Expression of transforming growth factor-β isoforms in human glomerular diseases.Kidney Int.1996; 49: 461–9.
40.
YoshiokaK., TakemuraT., MurakamiK., OkadaM., HinoS., MiyamotoH.Transforming growth factor-β protein and mRNA in glomeruli in normal and diseased human kidneys.Lab Invest.1993; 68: 154–63.
41.
FukuiM., N akamuraT., EbiharaI., ShiratoI., TominoY., KoideH.ECM gene expression and its modulation by insulin in diabetic rats.Diabetes.1992; 41: 1520–7.
42.
LucasC., BaldL., FendlyB.M., Mora-WormsM., FigariI., PatzerE.The autocrine production of transforming growth factor-β during lymphocyte activation. A study with a monoclonal antibody-based ELISA.J Immunol.1990; 145: 1415–22.
